• Revenue up 10% to $26.3m, Gross Profit Margin 29%, EBITDA up 200% to $2.1m
• Increased market share in US O&G, secured long-term trial with global gold producer
• Secured first PFAS remediation contract with US Department of Defence

SciDev Limited has delivered a solid Q3 FY25 performance, with revenue of $26.3 million, up 10% from Q2 FY25 ($23.8 million). Gross profit margin was 29%, and EBITDA increased 200% to $2.1 million, up from $0.7 million in Q2 FY25. The company continued to execute on its strategic priorities, successfully increasing market share in the US oil and gas (O&G) market and growing its presence with target exploration and production (E&P) operators in the Permian Basin, reducing overall customer concentration. SciDev also continued to advance multiple key mining opportunities and secured a long-term trial with a global gold producer in Australia. Additionally, the company secured its first PFAS (per- and polyfluoroalkyl substances) remediation contract with the US Department of Defence to treat investigation-derived waste containing PFAS 'forever chemicals' at its installations. The company's Domestic Water business remained active across multiple projects, including the construction of a $5.6 million water treatment facility on a major NSW infrastructure project. The company noted that while market conditions remain volatile, the demand for its proprietary chemistry remains strong, underpinning improved margins. However, client-driven delays in the Water and Mining businesses have resulted in the timing of revenue from some projects shifting into FY26.

The company expects growing market demand for its technologies, with a healthy business development pipeline across all business units. Demand for its proprietary chemistry remains strong, underpinning improved margins. However, client-driven delays in the Water and Mining businesses may see the timing of some revenues shift into early FY26, due to customer-led schedule changes and extended delivery windows.